PSU Profiles
Keywords
Last Name
Institution

Gerald Naccarelli

TitleProfessor
InstitutionCollege of Medicine
DepartmentMedicine
Address500 University Drive Hershey PA 17033
Phone7175313907

 Overview 
 overview
PREFERRED TITLE/ROLE:

Physician, Professor of Medicine

EDUCATION:

Fellowship, Cardiology, Indiana University Medical Center (1981)
Fellowship, Medicine, Penn State Milton S. Hershey Medical Center (1979)
Residency, Medicine, North Carolina Baptist Hospital (1978)
M.D., Penn State Hershey College of Medicine (1976)


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Baquero GA, Luck J, Naccarelli GV, Gonzalez MD, Banchs JE. Tricuspid valve incompetence following implantation of ventricular leads. Curr Heart Fail Rep. 2015 Apr; 12(2):150-7.
    View in: PubMed
  2. Naccarelli GV, Kowey PR. The role of dronedarone in the treatment of atrial fibrillation/flutter in the aftermath of PALLAS. Curr Cardiol Rev. 2014 Nov; 10(4):303-8.
    View in: PubMed
  3. Baquero GA, Banchs JE, Ahmed S, Naccarelli GV, Luck JC. Surface 12 lead electrocardiogram recordings using smart phone technology. J Electrocardiol. 2015 Jan-Feb; 48(1):1-7.
    View in: PubMed
  4. Naccarelli GV, Cappato R, Hohnloser SH, Marchlinski FE, Wilber DJ, Xiang J, Ma C, Hess S, Davies DW, Fields LE, Natale A. Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation. J Interv Card Electrophysiol. 2014 Nov; 41(2):107-16.
    View in: PubMed
  5. Sriram CS, Naccarelli GV, Luck JC. An atypical case of vagally mediated atrial fibrillation in an elderly woman: electrocardiographic caveats to diagnosis. J Electrocardiol. 2014 Sep-Oct; 47(5):734-7.
    View in: PubMed
  6. Foy A, Baquero GA, Naccarelli GV, Kozak M. Applying the diamond criteria could improve utilization of stress echocardiography for patients who present to the emergency department with low-risk chest pain. Crit Pathw Cardiol. 2014 Jun; 13(2):49-54.
    View in: PubMed
  7. Steinberg BA, Kim S, Fonarow GC, Thomas L, Ansell J, Kowey PR, Mahaffey KW, Gersh BJ, Hylek E, Naccarelli G, Go AS, Reiffel J, Chang P, Peterson ED, Piccini JP. Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2014 May; 167(5):735-42.e2.
    View in: PubMed
  8. Naccarelli GV. Dronedarone: an alternate choice to sotalol and amiodarone in the treatment of atrial fibrillation/flutter in patients who have coronary heart disease. Europace. 2014 Feb; 16(2):153-5.
    View in: PubMed
  9. Baquero GA, Yadav P, Skibba JB, Banchs JE, Linton-Frazier LN, Lengerich EJ, Samii SM, Penny-Peterson E, Wolbrette DL, Luck JC, Naccarelli GV, Gonzalez MD. Clinical significance of increased tricuspid valve incompetence following implantation of ventricular leads. J Interv Card Electrophysiol. 2013 Dec; 38(3):197-202.
    View in: PubMed
  10. Ferns SJ, Naccarelli G. ICDs in adults with congenital heart disease: an overview. Expert Rev Cardiovasc Ther. 2013 Dec; 11(12):1591-3.
    View in: PubMed
  11. Banchs JE, Baquero GA, Nickolaus MJ, Wolbrette DL, Kelleman JJ, Samii S, Grando-Ting J, Penny-Peterson E, Davidson WR, Young SK, Naccarelli GV, Gonzalez MD. Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease. Congenit Heart Dis. 2014 May-Jun; 9(3):221-7.
    View in: PubMed
  12. Naccarelli GV. Appropriate and inappropriate use of dronedarone in 2013. Curr Treat Options Cardiovasc Med. 2013 Aug; 15(4):467-75.
    View in: PubMed
  13. Ferns SJ, Naccarelli GV. Influence of blood pressure on atrial fibrillation. Expert Rev Cardiovasc Ther. 2013 Jun; 11(6):657-9.
    View in: PubMed
  14. Kowey PR, Naccarelli GV. The reply. Am J Med. 2013 Apr; 126(4):e23.
    View in: PubMed
  15. Steinberg BA, Holmes DN, Ezekowitz MD, Fonarow GC, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel J, Chang P, Peterson ED, Piccini JP. Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Am Heart J. 2013 Apr; 165(4):622-9.
    View in: PubMed
  16. Naccarelli GV, Gonzalez MD. Catheter ablation of atrial fibrillation: the need for studies to assess the efficacy and safety of novel anticoagulants. J Interv Card Electrophysiol. 2013 Jan; 36(1):3-4.
    View in: PubMed
  17. Kowey PR, Naccarelli GV. The Food and Drug Administration decision not to approve the 110 mg dose of dabigatran: give us a way out. Am J Med. 2012 Aug; 125(8):732.
    View in: PubMed
  18. Stowell SA, Gardner AJ, Alpert JS, Naccarelli GV, Harkins TP, Louder AM, Tamariz L. Impact of certified CME in atrial fibrillation on administrative claims. Am J Manag Care. 2012 May; 18(5):253-60.
    View in: PubMed
  19. Baquero G, Banchs JE, Naccarelli GV, Gonzalez M, Wolbrette DL. Cardiogenic shock as the initial presentation of systemic lupus erythematosus: a case report and review of the literature. Congest Heart Fail. 2012 Nov-Dec; 18(6):337-41.
    View in: PubMed
  20. Naccarelli GV, Panaccio MP, Cummins G, Tu N. CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients. Am J Cardiol. 2012 May 15; 109(10):1526-33.
    View in: PubMed
  21. Alberts MJ, Bernstein RA, Naccarelli GV, Garcia DA. Using dabigatran in patients with stroke: a practical guide for clinicians. Stroke. 2012 Jan; 43(1):271-9.
    View in: PubMed
  22. Naccarelli GV, Johnston SS, Dalal M, Lin J, Patel PP. Rates and implications for hospitalization of patients =65 years of age with atrial fibrillation/flutter. Am J Cardiol. 2012 Feb 15; 109(4):543-9.
    View in: PubMed
  23. Naccarelli GV, Wolbrette DL, Levin V, Samii S, Banchs JE, Penny-Peterson E, Gonzalez MD. Safety and efficacy of dronedarone in the treatment of atrial fibrillation/flutter. Clin Med Insights Cardiol. 2011; 5:103-19.
    View in: PubMed
  24. Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies. J Cardiovasc Electrophysiol. 2012 Mar; 23(3):296-301.
    View in: PubMed
  25. Samii SM, Naccarelli GV. Atrial fibrillation: AVRO--were the results a surprise? Nat Rev Cardiol. 2011 Apr; 8(4):188-90.
    View in: PubMed
  26. Naccarelli GV. Post-ATHENA and beyond. J Interv Card Electrophysiol. 2011 Jun; 31(1):55-60.
    View in: PubMed
  27. Naccarelli GV, Wolbrette DL, Samii S, Banchs JE, Penny-Peterson E, Gonzalez MD. A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission. J Cardiovasc Pharmacol Ther. 2010 Dec; 15(4 Suppl):24S-30S.
    View in: PubMed
  28. Naccarelli GV, Singh BN. Treatment of atrial fibrillation in 2010 and beyond. J Cardiovasc Pharmacol Ther. 2010 Dec; 15(4 Suppl):5.
    View in: PubMed
  29. Kowey PR, Reiffel JA, Ellenbogen KA, Naccarelli GV, Pratt CM. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. JAMA. 2010 Dec 1; 304(21):2363-72.
    View in: PubMed
  30. Baquero G, Banchs JE, Davidson WR, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, González MD. Cardiac resynchronization therapy: evaluation of ventricular dysynchrony and patient selection. Arch Cardiol Mex. 2010 Oct-Dec; 80(4):289-300.
    View in: PubMed
  31. Wolbrette D, Gonzalez M, Samii S, Banchs J, Penny-Peterson E, Naccarelli G. Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy. Vasc Health Risk Manag. 2010; 6:517-23.
    View in: PubMed
  32. Naccarelli GV, Curtis AB. Optimizing the management of atrial fibrillation: focus on current guidelines and the impact of new agents on future recommendations. J Cardiovasc Pharmacol Ther. 2010 Sep; 15(3):244-56.
    View in: PubMed
  33. Banchs JE, Patel P, Naccarelli GV, Gonzalez MD. Intracardiac echocardiography in complex cardiac catheter ablation procedures. J Interv Card Electrophysiol. 2010 Sep; 28(3):167-84.
    View in: PubMed
  34. Naccarelli GV, Johnston SS, Lin J, Patel PP, Schulman KL. Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States. Clin Cardiol. 2010 May; 33(5):270-9.
    View in: PubMed
  35. Prystowsky EN, Camm J, Lip GY, Allessie M, Bergmann JF, Breithardt G, Brugada J, Crijns H, Ellinor PT, Mark D, Naccarelli G, Packer D, Tamargo J. The impact of new and emerging clinical data on treatment strategies for atrial fibrillation. J Cardiovasc Electrophysiol. 2010 Aug 1; 21(8):946-58.
    View in: PubMed
  36. Arepally G, Bauer KA, Bhatt DL, Merli GJ, Naccarelli GV, Carter RD, Karcher RB, Berry CA, Keaton KL, Stowell SA. The use of antithrombotic therapies in the prevention and treatment of arterial and venous thrombosis: a survey of current knowledge and practice supporting the need for clinical education. Crit Pathw Cardiol. 2010 Mar; 9(1):41-8.
    View in: PubMed
  37. Reiffel JA, Kowey PR, Myerburg R, Naccarelli GV, Packer DL, Pratt CM, Reiter MJ, Waldo AL. Practice patterns among United States cardiologists for managing adults with atrial fibrillation (from the AFFECTS Registry). Am J Cardiol. 2010 Apr 15; 105(8):1122-9.
    View in: PubMed
  38. Kowey PR, Reiffel JA, Myerburg R, Naccarelli GV, Packer DL, Pratt CM, Reiter MJ, Waldo AL. Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry). Am J Cardiol. 2010 Apr 15; 105(8):1130-4.
    View in: PubMed
  39. Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009 Dec 1; 104(11):1534-9.
    View in: PubMed
  40. Naccarelli GV, Peacock F. Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation. Vasc Health Risk Manag. 2009; 5:783-91.
    View in: PubMed
  41. Pratt CM, Reiffel JA, Ellenbogen KA, Naccarelli GV, Kowey PR. Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study. Am Heart J. 2009 Aug; 158(2):163-169.e1-3.
    View in: PubMed
  42. Stevenson RT, Patel PP, Davidson WR, Naccarelli GV, Wolbrette DL, Samii SM, Banchs JE, Penny-Peterson ED, Gonzalez MD. Supernormal conduction and linking in an accessory AV pathway. J Interv Card Electrophysiol. 2011 Jan; 30(1):27-30.
    View in: PubMed
  43. Patel P, Banchs JE, Stevenson RT, Patel ND, Naccarelli GV, Wolbrette DL, Samii SM, Penny-Peterson ED, Gonzalez MD. Distal balloon occlusion allows epicardial lead placement in a tortuous branch of the great cardiac vein. J Interv Card Electrophysiol. 2009 Aug; 25(2):159-61.
    View in: PubMed
  44. Kadish AH, Reiffel JA, Naccarelli GV, DiMarco JP. Device therapies in the post-myocardial infarction patient with left ventricular dysfunction. Am J Cardiol. 2008 Sep 8; 102(5A):29G-37G.
    View in: PubMed
  45. Naccarelli GV, Gonzalez MD. Atrial fibrillation and the expanding role of catheter ablation: do antiarrhythmic drugs have a future? J Cardiovasc Pharmacol. 2008 Sep; 52(3):203-9.
    View in: PubMed
  46. Banchs JE, Wolbrette DL, Samii SM, Penny-Peterson ED, Patel PP, Young SK, Gonzalez MD, Naccarelli GV. Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter. J Interv Card Electrophysiol. 2008 Nov; 23(2):111-5.
    View in: PubMed
  47. Naccarelli GV, Wolbrette DL, Samii S, Banchs JE, Penny-Peterson E, Stevenson R, Gonzalez MD. Vernakalant: pharmacology electrophysiology, safety and efficacy. Drugs Today (Barc). 2008 May; 44(5):325-9.
    View in: PubMed
  48. Naccarelli GV, Wolbrette DL, Samii S, Banchs JE, Penny-Peterson E, Stevenson R, Gonzalez MD. Vernakalant--a promising therapy for conversion of recent-onset atrial fibrillation. Expert Opin Investig Drugs. 2008 May; 17(5):805-10.
    View in: PubMed
  49. Cohen M, Naccarelli GV. Pathophysiology and disease progression of atrial fibrillation: importance of achieving and maintaining sinus rhythm. J Cardiovasc Electrophysiol. 2008 Aug; 19(8):885-90.
    View in: PubMed
  50. Naccarelli GV, Conti JB, DiMarco JP, Tracy CM. Task force 6: training in specialized electrophysiology, cardiac pacing, and arrhythmia management endorsed by the Heart Rhythm Society. J Am Coll Cardiol. 2008 Jan 22; 51(3):374-80.
    View in: PubMed
  51. Goldschlager N, Epstein AE, Naccarelli GV, Olshansky B, Singh B, Collard HR, Murphy E. A practical guide for clinicians who treat patients with amiodarone: 2007. Heart Rhythm. 2007 Sep; 4(9):1250-9.
    View in: PubMed
  52. Naccarelli GV, Wolbrette DL, Samii S, Banchs JE, Penny-Peterson E, Gonzalez MD. New antiarrhythmic treatment of atrial fibrillation. Expert Rev Cardiovasc Ther. 2007 Jul; 5(4):707-14.
    View in: PubMed
  53. Banchs JE, Wolbrette DL, Naccarelli GV, Gonzalez MD. Paroxysmal atrioventricular block following a ventricular premature beat. J Cardiovasc Electrophysiol. 2007 Feb; 18(2):230.
    View in: PubMed
  54. Naccarelli GV. Ambulatory electrocardiographic monitoring: has mobile cardiac outpatient telemetry changed the playing field? J Cardiovasc Electrophysiol. 2007 Mar; 18(3):248-9.
    View in: PubMed
  55. Olshansky B, Kowey PR, Naccarelli GV. Fast-track training of nonelectrophysiologists to implant defibrillators: is it needed? Pacing Clin Electrophysiol. 2006 Jun; 29(6):627-31.
    View in: PubMed
  56. Linzer M, Myerburg RJ, Kutner JS, Wilcox CM, Oddone E, DeHoratius RJ, Naccarelli GV. Exploring the generalist-subspecialist interface in internal medicine. Am J Med. 2006 Jun; 119(6):528-37.
    View in: PubMed
  57. Naccarelli GV. Can incremental innovation of implantable cardioverter-defibrillator systems become disruptive to patient care? Moore's law gone awry. J Cardiovasc Electrophysiol. 2006 Jun; 17(6):621-2.
    View in: PubMed
  58. Reiffel JA, Naccarelli GV. Antiarrhythmic drug therapy for atrial fibrillation: are the guidelines guiding clinical practice? Clin Cardiol. 2006 Mar; 29(3):97-102.
    View in: PubMed
  59. Naccarelli GV, Conti JB, DiMarco JP, Tracy CM. Task Force 6: training in specialized electrophysiology, cardiac pacing, and arrhythmia management: endorsed by the Heart Rhythm Society. J Am Coll Cardiol. 2006 Feb 21; 47(4):904-10.
    View in: PubMed
  60. Naccarelli GV. Post myocardial infarction, left ventricular dysfunction, and the expanding role of cardiac implantable electrical devices. Clin Cardiol. 2005 Nov; 28(11 Suppl 1):I51-7.
    View in: PubMed
  61. Samii SM, Hynes BJ, Khan M, Wolbrette DL, Luck JC, Naccarelli GV. Selection of drugs in pursuit of rate control strategy. Prog Cardiovasc Dis. 2005 Sep-Oct; 48(2):146-52.
    View in: PubMed
  62. Naccarelli GV. Does carvedilol have antiarrhythmic properties? Nat Clin Pract Cardiovasc Med. 2005 Jul; 2(7):338-9.
    View in: PubMed
  63. Naccarelli GV. Antiadrenergic therapy in the control of atrial fibrillation. J Cardiovasc Pharmacol Ther. 2005 Jun; 10 Suppl 1:S33-43.
    View in: PubMed
  64. Naccarelli GV, Lukas MA. Carvedilol's antiarrhythmic properties: therapeutic implications in patients with left ventricular dysfunction. Clin Cardiol. 2005 Apr; 28(4):165-73.
    View in: PubMed
  65. Hynes BJ, Luck JC, Wolbrette DL, Khan M, Naccarelli GV. A review of the pharmacokinetics, electrophysiology and clinical efficacy of dronedarone. Future Cardiol. 2005 Mar; 1(2):135-44.
    View in: PubMed
  66. Murray KT, Rottman JN, Arbogast PG, Shemanski L, Primm RK, Campbell WB, Solomon AJ, Olgin JE, Wilson MJ, Dimarco JP, Beckman KJ, Dennish G, Naccarelli GV, Ray WA. Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM. Heart Rhythm. 2004 Dec; 1(6):669-75.
    View in: PubMed
  67. Naccarelli GV. Does it make sense to train plumbers as electricians? J Am Coll Cardiol. 2004 Oct 6; 44(7):1358-60.
    View in: PubMed
  68. Naccarelli GV. Can we predict antiarrhythmic efficacy or inefficacy of amiodarone or any other antiarrhythmic? What this patient needs is a doctor! J Cardiovasc Electrophysiol. 2004 Oct; 15(10):1155-6.
    View in: PubMed
  69. Baughman KL, Pepine CJ, Abrams J, Bashore TM, Califf RM, Feldman AM, Fye WB, Griffin BP, Myerburg RJ, Naccarelli GV, Williams ES. Working group 1: How to increase the output of cardiologists. J Am Coll Cardiol. 2004 Jul 21; 44(2):233-7.
    View in: PubMed
  70. Naccarelli GV. Implantable cardioverter-defibrillators: expanding indications. Curr Opin Cardiol. 2004 Jul; 19(4):317-22.
    View in: PubMed
  71. Naccarelli GV. Advances in the treatment of atrial fibrillation: the future is now. J Interv Card Electrophysiol. 2004; 10 Suppl 1:77-8.
    View in: PubMed
  72. Bhatta L, Luck JC, Wolbrette DL, Naccarelli GV. Complications of biventricular pacing. Curr Opin Cardiol. 2004 Jan; 19(1):31-5.
    View in: PubMed
  73. Hynes BJ, Mart C, Artman S, Pu M, Naccarelli GV. Role of intracardiac ultrasound in interventional electrophysiology. Curr Opin Cardiol. 2004 Jan; 19(1):52-7.
    View in: PubMed
  74. Naccarelli GV, Hynes BJ, Wolbrette DL, Bhatta L, Khan M, Samii S, Luck JC. Atrial fibrillation in heart failure: prognostic significance and management. J Cardiovasc Electrophysiol. 2003 Dec; 14(12 Suppl):S281-6.
    View in: PubMed
  75. Naccarelli GV, Wolbrette DL, Bhatta L, Khan M, Hynes J, Samii S, Luck J. A review of clinical trials assessing the efficacy and safety of newer antiarrhythmic drugs in atrial fibrillation. J Interv Card Electrophysiol. 2003 Oct; 9(2):215-22.
    View in: PubMed
  76. Hayes DL, Naccarelli GV, Furman S, Parsonnet V, Reynolds D, Goldschlager N, Gillette P, Maloney JD, Saxon L, Leon A, Daoud E. NASPE training requirements for cardiac implantable electronic devices: selection, implantation, and follow-up. Pacing Clin Electrophysiol. 2003 Jul; 26(7 Pt 1):1556-62.
    View in: PubMed
  77. Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Am J Cardiol. 2003 Mar 20; 91(6A):15D-26D.
    View in: PubMed
  78. Hynes BJ, Luck JC, Wolbrette DL, Bhatta L, Khan M, Samii S, Naccarelli GV. Atrial fibrillation in patients with heart failure. Curr Opin Cardiol. 2003 Jan; 18(1):32-8.
    View in: PubMed
  79. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol. 2002 Nov 6; 40(9):1703-19.
    View in: PubMed
  80. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL, Gibbons RI, Antman EM, Alpert JS, Hiratzka LF, Faxon DP, Jacobs AK, Fuster V, Smith SC. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Cardiovasc Electrophysiol. 2002 Nov; 13(11):1183-99.
    View in: PubMed
  81. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL, Gibbons RJ, Antman EM, Alpert JS, Gregoratos G, Hiratzka LF, Faxon DP, Jacobs AK, Fuster V, Smith SC. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation. 2002 Oct 15; 106(16):2145-61.
    View in: PubMed
  82. Naccarelli GV, Hynes J, Wolbrette DL, Bhatta L, Khan M, Luck J. Maintaining stability of sinus rhythm in atrial fibrillation: antiarrhythmic drugs versus ablation. Curr Cardiol Rep. 2002 Sep; 4(5):418-25.
    View in: PubMed
  83. Luck JC, Bhatta L, Artman SE, Wolbrette DL, Pantelloni MA, Naccarelli GV. Entrainment of ventricular tachycardia with a permanent biventricular pacemaker. J Interv Card Electrophysiol. 2002 Aug; 7(1):105-11.
    View in: PubMed
  84. McNulty PH, Sun B, Naccarelli GV, Ettinger SM. Left ventricular aneurysm as a consequence of hypertrophic obstructive cardiomyopathy. Catheter Cardiovasc Interv. 2002 Mar; 55(3):385-8.
    View in: PubMed
  85. Wolbrette D, Naccarelli G, Curtis A, Lehmann M, Kadish A. Gender differences in arrhythmias. Clin Cardiol. 2002 Feb; 25(2):49-56.
    View in: PubMed
  86. Luck JC, Wolbrette DL, Boehmer JP, Ulsh PJ, Silber D, Naccarelli GV. Biventricular pacing in congestive heart failure: a boost toward finer living. Curr Opin Cardiol. 2002 Jan; 17(1):96-101.
    View in: PubMed
  87. Naccarelli GV, Antzelevitch C, Wolbrette DL, Luck JC. The Brugada syndrome. Curr Opin Cardiol. 2002 Jan; 17(1):19-23.
    View in: PubMed
  88. Naccarella F, Naccarelli GV, Maranga SS, Lepera G, Grippo MC, Melandri F, Gatti M, Pazzaglia S, Spinelli G, Angelini V, Ambrosioni E, Borghi C, Giovagnorio MT, Nisam S. Do ACE inhibitors or angiotensin II antagonists reduce total mortality and arrhythmic mortality? A critical review of controlled clinical trials. Curr Opin Cardiol. 2002 Jan; 17(1):6-18.
    View in: PubMed
  89. Estes NA, Link MS, Cannom D, Naccarelli GV, Prystowsky EN, Maron BJ, Olshansky B. Report of the NASPE policy conference on arrhythmias and the athlete. J Cardiovasc Electrophysiol. 2001 Oct; 12(10):1208-19.
    View in: PubMed
  90. Saksena S, Domanski MJ, Benjamin EJ, Camm AJ, Ezekowitz MD, Gersh BJ, Jalife J, Naccarelli GV, Vlietstra RE, Wyse DG. Report of the NASPE/NHLBI round table on future research directions in atrial fibrillation. Pacing Clin Electrophysiol. 2001 Sep; 24(9 Pt 1):1435-51.
    View in: PubMed
  91. Saskena S, Domanski MJ, Benjamin EJ, Camm AJ, Ezekowitz MD, Gersh BJ, Jalife J, Naccarelli GV, Vlietstra RE, Wyse DG. Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology. J Interv Card Electrophysiol. 2001 Sep; 5(3):345-64.
    View in: PubMed
  92. Lindsay BD, Kutalek SP, Cannom DS, Hammill SC, Naccarelli GV. Reprocessing of electrophysiology catheters: clinical studies, regulations, and recommendations. A report of the NASPE Task Force on Reprocessing of Electrophysiological Catheters. North American Society of Pacing and Electrophysiology. Pacing Clin Electrophysiol. 2001 Aug; 24(8 Pt 1):1297-305.
    View in: PubMed
  93. Naccarelli GV, Antzelevitch C. The Brugada syndrome: clinical, genetic, cellular, and molecular abnormalities. Am J Med. 2001 May; 110(7):573-81.
    View in: PubMed
  94. Naccarelli GV, Wolbrette DL, Luck JC. Proarrhythmia. Med Clin North Am. 2001 Mar; 85(2):503-26, xii.
    View in: PubMed
  95. Dell'Orfano JT, Naccarelli GV. Update on external cardioversion and defibrillation. Curr Opin Cardiol. 2001 Jan; 16(1):54-7.
    View in: PubMed
  96. Wolbrette DL, Naccarelli GV. Management of implantable cardioverter defibrillator patients: role of predischarge electrophysiologic testing and proper patient instruction before hospital discharge. Curr Opin Cardiol. 2001 Jan; 16(1):72-5.
    View in: PubMed
  97. Naccarella F, Naccarelli G, Fattori R, Nava A, Martini B, Corrado D, Masotti A, Gatti M. Arrhythmogenic right ventricular dysplasia: cardiomyopathy current opinions on diagnostic and therapeutic aspects. Curr Opin Cardiol. 2001 Jan; 16(1):8-16.
    View in: PubMed
  98. Wolbrette DL, Naccarelli GV. Emerging indications for permanent pacing. Curr Cardiol Rep. 2000 Jul; 2(4):353-60.
    View in: PubMed
  99. Goldschlager N, Epstein AE, Naccarelli G, Olshansky B, Singh B. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology. Arch Intern Med. 2000 Jun 26; 160(12):1741-8.
    View in: PubMed
  100. Naccarelli GV, Dell'Orfano JT, Wolbrette DL, Patel HM, Luck JC. Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy. Am J Cardiol. 2000 May 25; 85(10A):36D-45D.
    View in: PubMed
  101. Naccarelli GV, Wolbrette DL, Dell'Orfano JT, Patel HM, Luck JC. Amiodarone: what have we learned from clinical trials? Clin Cardiol. 2000 Feb; 23(2):73-82.
    View in: PubMed
  102. Naccarelli GV, Wolbrette DL, Patel HM, Luck JC. Amiodarone: clinical trials. Curr Opin Cardiol. 2000 Jan; 15(1):64-72.
    View in: PubMed
  103. Dell'Orfano JT, Kramer RK, Naccarelli GV. Cost-effective strategies in the acute management of atrial fibrillation. Curr Opin Cardiol. 2000 Jan; 15(1):23-8.
    View in: PubMed
  104. Saxon LA, Boehmer JP, Hummel J, Kacet S, De Marco T, Naccarelli G, Daoud E. Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. The VIGOR CHF and VENTAK CHF Investigators. Am J Cardiol. 1999 Mar 11; 83(5B):120D-123D.
    View in: PubMed
  105. Dell'Orfano JT, Patel H, Wolbrette DL, Luck JC, Naccarelli GV. Acute treatment of atrial fibrillation: spontaneous conversion rates and cost of care. Am J Cardiol. 1999 Mar 1; 83(5):788-90, A10.
    View in: PubMed
  106. Naccarelli GV, Luck JC, Wolbrette DL, Pae WE, Weller-Moore R, Dell'Orfano JT, Patel HM, Boehmer JP. Pacing therapy for congestive heart failure: is it ready for prime time? Curr Opin Cardiol. 1999 Jan; 14(1):1-3.
    View in: PubMed
  107. Naccarelli GV, Wolbrette DL, Dell'Orfano JT, Patel HM, Luck JC. A decade of clinical trial developments in postmyocardial infarction, congestive heart failure, and sustained ventricular tachyarrhythmia patients: from CAST to AVID and beyond. Cardiac Arrhythmic Suppression Trial. Antiarrhythmic Versus Implantable Defibrillators. J Cardiovasc Electrophysiol. 1998 Aug; 9(8):864-91.
    View in: PubMed
  108. Reynolds DW, Naccarelli GV, Wilber DJ. NASPE expert consensus statement: physician workforce in cardiac electrophysiology and pacing. NASPE task force, Washington, D.C. Pacing Clin Electrophysiol. 1998 Aug; 21(8):1646-55.
    View in: PubMed
  109. Dell'Orfano JT, Luck JC, Wolbrette DL, Patel H, Naccarelli GV. Drugs for conversion of atrial fibrillation. Am Fam Physician. 1998 Aug; 58(2):471-80.
    View in: PubMed
  110. Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TB, Freedman RA, Hlatky MA, Naccarelli GV, Saksena S, Schlant RC, Silka MJ. ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary--a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). Circulation. 1998 Apr 7; 97(13):1325-35.
    View in: PubMed
  111. Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TB, Freedman RA, Hlatky MA, Naccarelli GV, Saksena S, Schlant RC, Silka MJ, Ritchie JL, Gibbons RJ, Cheitlin MD, Eagle KA, Gardner TJ, Lewis RP, O'Rourke RA, Ryan TJ, Garson A. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol. 1998 Apr; 31(5):1175-209.
    View in: PubMed
  112. Naccarelli GV, Alagona P, Kramer RK. Can electrophysiologists survive the new era of health care reform? Pacing Clin Electrophysiol. 1997 Aug; 20(8 Pt 1):2008-11.
    View in: PubMed
  113. Naccarelli GV. Health care reform: effects on electrophysiology and pacing. Curr Opin Cardiol. 1997 Jan; 12(1):1-2.
    View in: PubMed
  114. Naccarelli GV, Lee KS, Gibson JK, VanderLugt J. Electrophysiology and pharmacology of ibutilide. Am J Cardiol. 1996 Oct 17; 78(8A):12-6.
    View in: PubMed
  115. Stevens SK, Haffajee CI, Naccarelli GV, Schwartz KM, Luceri RM, Packer DL, Rubin AM, Kowey PR. Effects of oral propafenone on defibrillation and pacing thresholds in patients receiving implantable cardioverter-defibrillators. Propafenone Defibrillation Threshold Investigators. J Am Coll Cardiol. 1996 Aug; 28(2):418-22.
    View in: PubMed
  116. Prystowsky EN, Benson DW, Fuster V, Hart RG, Kay GN, Myerburg RJ, Naccarelli GV, Wyse DG. Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation. 1996 Mar 15; 93(6):1262-77.
    View in: PubMed
  117. Dorian P, Naccarelli GV, Coumel P, Hohnloser SH, Maser MJ. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group. Am J Cardiol. 1996 Jan 25; 77(3):89A-95A.
    View in: PubMed
  118. Naccarelli GV, Dorian P, Hohnloser SH, Coumel P. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group. Am J Cardiol. 1996 Jan 25; 77(3):53A-59A.
    View in: PubMed
  119. Naccarelli GV, Jalal S. Intravenous amiodarone. Another option in the acute management of sustained ventricular tachyarrhythmias. Circulation. 1995 Dec 1; 92(11):3154-5.
    View in: PubMed
  120. Naccarelli GV, Shih HT, Jalal S. Catheter ablation for the treatment of paroxysmal supraventricular tachycardia. J Cardiovasc Electrophysiol. 1995 Oct; 6(10 Pt 2):951-61.
    View in: PubMed
  121. Gilman JK, Jalal S, Naccarelli GV. Predicting and preventing sudden death from cardiac causes. Circulation. 1994 Aug; 90(2):1083-92.
    View in: PubMed
  122. Naccarelli GV. Trends in subspecialty training in cardiac electrophysiology and pacing. Pacing Clin Electrophysiol. 1994 Feb; 17(2):242-4.
    View in: PubMed
  123. Hayes DL, Naccarelli GV, Furman S, Parsonnet V. Report of the NASPE Policy Conference training requirements for permanent pacemaker selection, implantation, and follow-up. North American Society of Pacing and Electrophysiology. Pacing Clin Electrophysiol. 1994 Jan; 17(1):6-12.
    View in: PubMed
  124. Dougherty AH, Gilman JK, Wiggins S, Jalal S, Naccarelli GV. Provocation of atrioventricular reentry tachycardia: a paradoxical effect of adenosine. Pacing Clin Electrophysiol. 1993 Jan; 16(1 Pt 1):8-12.
    View in: PubMed
  125. Gilman JK, Naccarelli GV. Sudden cardiac death. Curr Probl Cardiol. 1992 Nov; 17(11):693-778.
    View in: PubMed
  126. Dougherty AH, Jackman WM, Naccarelli GV, Friday KJ, Dias VC. Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. IV Diltiazem Study Group. Am J Cardiol. 1992 Sep 1; 70(6):587-92.
    View in: PubMed
  127. DiMarco JP, Prystowsky EN, Ellenbogen KA, Horowitz LN, Naccarelli GV, Jackman WM, Laks MM. Catheter ablation in patients with cardiac arrhythmias. Circulation. 1992 Jan; 85(1):390.
    View in: PubMed
  128. Jackman WM, Wang XZ, Friday KJ, Fitzgerald DM, Roman C, Moulton K, Margolis PD, Bowman AJ, Kuck KH, Naccarelli GV, et al. Catheter ablation of atrioventricular junction using radiofrequency current in 17 patients. Comparison of standard and large-tip catheter electrodes. Circulation. 1991 May; 83(5):1562-76.
    View in: PubMed
  129. Naccarelli GV, Dougherty AH, Ott DA, Jackman WM. Surgical and catheter ablative techniques for treating supraventricular tachycardia. Appl Cardiopulm Pathophysiol. 1991; 4(1):27-32.
    View in: PubMed
  130. Naccarelli GV, Dougherty AH, Wolbrette D, Wiggins S. A critical appraisal of the cardiac arrhythmia suppression trial (CAST). Appl Cardiopulm Pathophysiol. 1991; 4(1):9-16.
    View in: PubMed
  131. Berns E, Naccarelli GV. Management of tachyarrhythmias after MI. Hosp Pract (Off Ed). 1990 Apr 15; 25(4):33-43.
    View in: PubMed
  132. Rinkenberger RL, Naccarelli GV. Evaluation and acute treatment of wide complex tachycardias. Crit Care Clin. 1989 Jul; 5(3):599-641.
    View in: PubMed
  133. Naccarelli GV, Rinkenberger RL, Dougherty AH, Fitzgerald DM. Adverse effects of amiodarone. Pathogenesis, incidence and management. Med Toxicol Adverse Drug Exp. 1989 Jul-Aug; 4(4):246-53.
    View in: PubMed
  134. Rinkenberger RL, Naccarelli GV. Evaluation and treatment of narrow complex tachycardias. Crit Care Clin. 1989 Jul; 5(3):569-97.
    View in: PubMed
  135. Niazi I, Naccarelli G, Dougherty A, Rinkenberger R, Tchou P, Akhtar M. Treatment of atrioventricular node reentrant tachycardia with encainide: reversal of drug effect with isoproterenol. J Am Coll Cardiol. 1989 Mar 15; 13(4):904-10.
    View in: PubMed
  136. Naccarelli GV, Goldstein RA. Electrophysiology of phosphodiesterase inhibitors. Am J Cardiol. 1989 Jan 3; 63(2):35A-40A.
    View in: PubMed
  137. Naccarelli GV, Wellens HJ. Advances in the treatment of supraventricular tachycardia. Am J Cardiol. 1988 Dec 20; 62(19):1L-3L.
    View in: PubMed
  138. Miles WM, Zipes DP, Rinkenberger RL, Markel ML, Prystowsky EN, Dougherty AH, Heger JJ, Naccarelli GV. Encainide for treatment of atrioventricular reciprocating tachycardia in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1988 Dec 20; 62(19):20L-25L.
    View in: PubMed
  139. Rinkenberger RL, Naccarelli GV, Miles WM, Markel ML, Dougherty AH, Prystowsky EN, Heger JJ, Zipes DP. Encainide for atrial fibrillation associated with Wolff-Parkinson-White syndrome. Am J Cardiol. 1988 Dec 20; 62(19):26L-30L.
    View in: PubMed
  140. Naccarelli GV, Jackman WM, Akhtar M, Rinkenberger RL, Friday KJ, Dougherty AH, Tchou P, Yeung-Lai-Wah JA. Efficacy and electrophysiologic effects of encainide for atrioventricular nodal reentrant tachycardia. Am J Cardiol. 1988 Dec 20; 62(19):31L-36L.
    View in: PubMed
  141. Akhtar M, Niazi I, Naccarelli GV, Tchou P, Rinkenberger R, Dougherty AH, Jazayeri M. Role of adrenergic stimulation by isoproterenol in reversal of effects of encainide in supraventricular tachycardia. Am J Cardiol. 1988 Dec 20; 62(19):45L-49L.
    View in: PubMed
  142. Rinkenberger RL, Naccarelli GV, Leahy E, Dougherty AH. Invasive and noninvasive evaluation of arrhythmias. Hosp Pract (Off Ed). 1988 Nov 15; 23(11):115-20, 125-35.
    View in: PubMed
  143. Jackman WM, Kuck KH, Naccarelli GV, Carmen L, Pitha J. Radiofrequency current directed across the mitral anulus with a bipolar epicardial-endocardial catheter electrode configuration in dogs. Circulation. 1988 Nov; 78(5 Pt 1):1288-98.
    View in: PubMed
  144. Naccarelli GV, Rinkenberger RL, Dougherty AH, Berns E, Crandell JR. Pharmacologic therapy of arrhythmias. Hosp Pract (Off Ed). 1988 Oct 15; 23(10):183-7, 190-2, 194-5 passim.
    View in: PubMed
  145. Rinkenberger RL, Naccarelli GV, Berns E, Dougherty AH. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia. Am J Cardiol. 1988 Aug 25; 62(6):44D-55D.
    View in: PubMed
  146. Kuck KH, Kunze KP, Schlüter M, Geiger M, Jackman WM, Naccarelli GV. Modification of a left-sided accessory atrioventricular pathway by radiofrequency current using a bipolar epicardial-endocardial electrode configuration. Eur Heart J. 1988 Aug; 9(8):927-32.
    View in: PubMed
  147. Andreoli TE, Naccarelli GV. Cardiac arrhythmias: our knowledge and our power. Hosp Pract (Off Ed). 1988 Jun 15; 23(6):15-6.
    View in: PubMed
  148. Berns E, Rinkenberger RL, Jeang MK, Dougherty AH, Jenkins M, Naccarelli GV. Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation. Am J Cardiol. 1987 Jun 1; 59(15):1337-41.
    View in: PubMed
  149. Dougherty AH, Naccarelli GV. Characteristics of ventriculoatrial conduction in patients with enhanced atrioventricular nodal conduction. Pacing Clin Electrophysiol. 1987 Jan; 10(1 Pt 1):32-40.
    View in: PubMed
  150. Lal R, Chapman PD, Naccarelli GV, Schechtman KB, Rinkenberger RL, Troup PJ, Kim SS, Dougherty AH, Ruffy R. Flecainide in the treatment of nonsustained ventricular tachycardia. Ann Intern Med. 1986 Oct; 105(4):493-8.
    View in: PubMed
  151. Naccarelli GV, Dougherty AH, Berns E, Rinkenberger RL. Assessment of antiarrhythmic drug efficacy in the treatment of supraventricular arrhythmias. Am J Cardiol. 1986 Aug 29; 58(5):31C-36C.
    View in: PubMed
  152. Dougherty AH, Rinkenberger RL, Naccarelli GV. Effect of pharmacologic autonomic blockade on ventriculoatrial conduction. Am J Cardiol. 1986 Jun 1; 57(15):1274-9.
    View in: PubMed
  153. Goldstein RA, Geraci SA, Gray EL, Rinkenberger RL, Dougherty AH, Naccarelli GV. Electrophysiologic effects of milrinone in patients with congestive heart failure. Am J Cardiol. 1986 Mar 1; 57(8):624-8.
    View in: PubMed
  154. Naccarelli GV, Rinkenberger RL, Dougherty AH, Giebel RA. Amiodarone: pharmacology and antiarrhythmic and adverse effects. Pharmacotherapy. 1985 Nov-Dec; 5(6):298-313.
    View in: PubMed
  155. Goldstein RA, Naccarelli GV. Intravenous amrinone. Ann Intern Med. 1985 Oct; 103(4):643-4.
    View in: PubMed
  156. Naccarelli GV, Fineberg NS, Zipes DP, Heger JJ, Duncan G, Prystowsky EN. Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study. J Am Coll Cardiol. 1985 Oct; 6(4):814-21.
    View in: PubMed
  157. Goldstein RA, Gray EL, Dougherty AH, Naccarelli GV. Electrophysiologic effects of amrinone. Am J Cardiol. 1985 Jul 22; 56(3):25B-28B.
    View in: PubMed
  158. Dougherty AH, Naccarelli GV, Gray EL, Hicks CH, Goldstein RA. Congestive heart failure with normal systolic function. Am J Cardiol. 1984 Oct 1; 54(7):778-82.
    View in: PubMed
  159. Naccarelli GV. Evaluation of the patient with syncope. Med Clin North Am. 1984 Sep; 68(5):1211-30.
    View in: PubMed
  160. Naccarelli GV, Gray EL, Dougherty AH, Hanna JE, Goldstein RA. Amrinone: acute electrophysiologic and hemodynamic effects in patients with congestive heart failure. Am J Cardiol. 1984 Sep 1; 54(6):600-4.
    View in: PubMed
  161. Prystowsky EN, Klein GJ, Rinkenberger RL, Heger JJ, Naccarelli GV, Zipes DP. Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome. Circulation. 1984 Feb; 69(2):278-87.
    View in: PubMed
  162. Jackman WM, Prystowsky EN, Naccarelli GV, Fineberg NS, Rahilly GT, Heger JJ, Zipes DP. Reevaluation of enhanced atrioventricular nodal conduction: evidence to suggest a continuum of normal atrioventricular nodal physiology. Circulation. 1983 Feb; 67(2):441-8.
    View in: PubMed
  163. Prystowsky EN, Naccarelli GV, Jackman WM, Rinkenberger RL, Heger JJ, Zipes DP. Enhanced parasympathetic tone shortens atrial refractoriness in man. Am J Cardiol. 1983 Jan 1; 51(1):96-100.
    View in: PubMed
  164. Naccarelli GV, Zipes DP, Rahilly GT, Heger JJ, Prystowsky EN. Influence of tachycardia cycle length and antiarrhythmic drugs on pacing termination and acceleration of ventricular tachycardia. Am Heart J. 1983 Jan; 105(1):1-5.
    View in: PubMed
  165. Gulamhusein S, Naccarelli GV, Ko PT, Prystowsky EN, Zipes DP, Barnett HJ, Heger JJ, Klein GJ. Value and limitations of clinical electrophysiologic study in assessment of patients with unexplained syncope. Am J Med. 1982 Nov; 73(5):700-5.
    View in: PubMed
  166. Rahilly GT, Prystowsky EN, Zipes DP, Naccarelli GV, Jackman WM, Heger JJ. Clinical and electrophysiologic findings in patients with repetitive monomorphic ventricular tachycardia and otherwise normal electrocardiogram. Am J Cardiol. 1982 Sep; 50(3):459-68.
    View in: PubMed
  167. Naccarelli GV, Prystowsky EN, Jackman WM, Heger JJ, Rahilly GT, Zipes DP. Role of electrophysiologic testing in managing patients who have ventricular tachycardia unrelated to coronary artery disease. Am J Cardiol. 1982 Jul; 50(1):165-71.
    View in: PubMed
  168. Zipes DP, Jackman WM, Heger JJ, Chilson DA, Browne KF, Naccarelli GV, Rahilly GT, Prystowsky EN. Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode. Am Heart J. 1982 May; 103(5):789-94.
    View in: PubMed
  169. Jackman WM, Zipes DP, Naccarelli GV, Rinkenberger RL, Heger JJ, Prystowsky EN. Electrophysiology of oral encainide. Am J Cardiol. 1982 Apr 1; 49(5):1270-8.
    View in: PubMed
  170. Prystowsky EN, Heger JJ, Jackman WM, Naccarelli GV, Zipes DP. Post-myocardial infarction incessant supraventricular tachycardia due to concealed accessory pathway. Am Heart J. 1982 Mar; 103(3):426-30.
    View in: PubMed
  171. Rinkenberger RL, Prystowsky EN, Jackman WM, Naccarelli GV, Heger JJ, Zipes DP. Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: identification of drugs that exacerbate tachycardia and potential mechanisms. Am Heart J. 1982 Feb; 103(2):177-84.
    View in: PubMed
  172. Ko PT, Naccarelli GV, Gulamhusein S, Prystowsky EN, Zipes DP, Klein GJ. Atrioventricular dissociation during paroxysmal junctional tachycardia. Pacing Clin Electrophysiol. 1981 Nov; 4(6):670-8.
    View in: PubMed
  173. Heger JJ, Prystowsky EN, Jackman WM, Naccarelli GV, Warfel KA, Rinkenberger RL, Zipes DP. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N Engl J Med. 1981 Sep 3; 305(10):539-45.
    View in: PubMed
  174. Naccarelli GV, Prystowsky EN, Jackman WM, Heger JJ, Rinkenberger RL, Zipes DP. Repetitive ventricular response. Prevalence and prognostic significance. Br Heart J. 1981 Aug; 46(2):152-8.
    View in: PubMed
  175. Naccarelli GV, Haisty WK, Kahl FR. Left ventricular to right atrial defect and tricuspid insufficiency secondary to nonpenetrating cardiac trauma. J Trauma. 1980 Oct; 20(10):887-91.
    View in: PubMed
  176. Naccarelli GV, Nomeir AM, Watts LE, Zelis R. Echocardiographic assessment of mitral stenosis by the left atrial emptying index. Chest. 1979 Dec; 76(6):668-71.
    View in: PubMed
Naccarelli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_